Xiaoyan Zhou

Mrs. Xiaoyan Zhou

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
CYChangjiang Ying
Changjiang Ying
YMYizhen Mao
Yizhen Mao
LCLei Chen
Lei Chen
SWShanshan Wang
Shanshan Wang
HLHongwei Ling
Hongwei Ling
XZXiaoyan Zhou
Xiaoyan Zhou

26 September 2022 in Brain Research Bulletin
Verified
Journal Article
Closed access
ZZZhongyuan Zhou
Zhongyuan Zhou
MWMeng Wang
Meng Wang
CHChengyu Huang
Chengyu Huang
YLYan Li
Yan Li
LGLin Gao
Lin Gao
XZXiaoyan Zhou
Xiaoyan Zhou

1 January 2019 in Pharmaceutical Biology
Verified
Journal Article
Open access
YSYuanjian Song
Yuanjian Song
LQLi Qin
Li Qin
RYRongli Yang
Rongli Yang
FYFan Yang
Fan Yang
NKNwobodo Alexander Kenechukwu
Nwobodo Alexander Kenechukwu
LLLei Li
Lei Li
Context: Researchers in a variety of fields have extensively focused on histone deacetylase 6 (HDAC6) due to its aggravation of inflammatory reaction. However, relevant studies examining whether HDAC6 could exacerbate lipopolysaccharide (LPS)-induced inflammation are still lacking. Objective: We assessed the role of HDAC6 in LPS-induced brain inflammation and used the HDAC6-selective inhibitor Tubastatin A (TBSA) to investigate the potential mechanisms further. Materials and methods: Brain inflammation was induced in Kunming (KM) mice via intraperitoneal (I.P.), injection of Lipopolysaccharide (LPS) (1 mg/kg), the TBSA (0.5 mg/kg) was delivered via intraperitoneal. The phosphorylated p38 (p-p38) Mitogen-activated protein kinases (MAPK) and expression of typical inflammatory mediators, including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in both the hippocampus and cortex, were examined by immunoblotting. Nissl staining was used to detect the neuronal damage in the hippocampus and the cortex. Results: About 1 mg/kg LPS via daily intraperitoneal (I.P.) injections for 12 days significantly increased p38 MAPK phosphorylation, TNF-α and IL-6 expression, and neuronal loss. However, 0.5 mg/kg TBSA (three days before LPS treatment) by I.P. injections for 15 days could reverse the above results. Conclusions: This present study provided evidence that TBSA significantly suppressed LPS-induced neuroinflammation and the expression of p-p38. Results derived from our study might help reveal the effective targeting strategies of LPS-induced brain inflammation through inhibiting HDAC6.

1 June 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
CYChangjiang Ying
Changjiang Ying
LCLei Chen
Lei Chen
SWShanshan Wang
Shanshan Wang
YMYizhen Mao
Yizhen Mao
HLHongwei Ling
Hongwei Ling
XZXiaoyan Zhou
Xiaoyan Zhou

1 January 2019 in Archives of Medical Science
Verified
Journal Article
Open access
PDF file
CYChangjiang Ying
Changjiang Ying
SWShanshan Wang
Shanshan Wang
YLYan Lu
Yan Lu
LCLei Chen
Lei Chen
YMYizhen Mao
Yizhen Mao
XZXiaoyan Zhou
Xiaoyan Zhou
Introduction Blood glucose fluctuation is an important factor for the development of diabetic complications. Glucose fluctuation aggravated the renal injury in diabetic nephropathy. In the present study, our aim was to investigate the effects of blood glucose fluctuation on the glomerular...

14 January 2022 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
CYChangjiang Ying
Changjiang Ying
ZZZhongyuan Zhou
Zhongyuan Zhou
JDJiao Dai
Jiao Dai
MWMeng Wang
Meng Wang
JXJie Xiang
Jie Xiang
XZXiaoyan Zhou
Xiaoyan Zhou